We studied Ebolavirus infection transcriptome-wide across multiple systems to monitor transcriptional dynamics following controlled infection. We report here induction of the nuclear factor MAF in cells following infection with Ebolavirus: in primary human hepatocytes, and in hepatocytes derived from induced pluripotent stem cells.
openaire +1 more source
Why is there still no licensed vaccine for Bundibugyo ebolavirus? Lessons from the 2026 outbreaks in Uganda and the Democratic Republic of Congo. [PDF]
Abdi AM +4 more
europepmc +1 more source
2026 Bundibugyo virus outbreak: the role of genomics in <i>Orthoebolavirus</i> outbreaks. [PDF]
Houldcroft CJ.
europepmc +1 more source
The Impact of Diagnostic Delays and Timeliness of Response on Ebola Disease outbreak-level case-fatality Ratios in Uganda (2000-2023): a Rapid Systematic Review and meta-analysis. [PDF]
Paasi G +3 more
europepmc +2 more sources
Bundibugyo Ebola in the Democratic Republic of the Congo and Uganda: A PHEIC in a countermeasure gap. [PDF]
Omar MA, Abdule AA.
europepmc +1 more source
Healthcare-associated transmission and early IPC system vulnerabilities during the 2026 Bundibugyo Ebola outbreak in eastern Democratic Republic of the Congo. [PDF]
Bepouka B, Kafua M.
europepmc +1 more source
Engineered bispecific antibodies achieve broad and potent protection against multiple ebolavirus species. [PDF]
Zhou J +15 more
europepmc +1 more source
A highly potent nanobody-based bispecific therapeutic provides broad-spectrum protection against ebolavirus. [PDF]
Wang M +22 more
europepmc +1 more source
Pan-filovirus activity of an IGF2-fused monoclonal antibody: Impairment by IGF1R cross-engagement and rescue via IGF2 Y27L mutation. [PDF]
Hu W +17 more
europepmc +1 more source
Ongoing guidance for infectious disease care for migrants and immigrants: a case-based narrative review. [PDF]
Croxton R +4 more
europepmc +1 more source

